Why the study?
Does increased BMI or waist circumference associate with a reduced prevalence of angiographic CAD in patients with suspected stable CAD?
Does increased BMI or waist circumference associate with a reduced prevalence of angiographic CAD in patients with suspected stable CAD?
Central and overall obesity are paradoxically associated with a reduced prevalence of angiographic CAD, supporting the 'obesity paradox' and improving risk discrimination when added to the Framingham risk score.
Should not alter CAD evaluation in stable suspects; supports obesity paradox yet leaves causal role open for prospective studies.
OBJECTIVE: Increased body mass index (BMI) has been paradoxically inversely associated with the presence of angiographic coronary artery disease (CAD). Central obesity measures, considered to be more appropriate for assessing obesity-related cardiovascular risk, have been little studied in relation to the presence of CAD. The aim was to investigate the association of central obesity with the presence of angiographic CAD as well as the prognostic significance of obesity measures in CAD prediction when added to other cardiovascular risk factors. DESIGN AND METHODS: Patients with suspected stable CAD (n = 403, age 61 ± 10 years, 302 males) referred for diagnostic coronary angiography with documented anthropometric data were enrolled. RESULTS: Significant angiographic CAD was found in 51% of patients. Both BMI (OR = 0.64 per 1 SD increase, P = 0.001) and waist circumference (WC) (OR = 0.54 per 1 SD increase, P < 0.001) were inversely associated with the presence of CAD even after adjustment for cardiovascular risk factors. In subgroup analysis, BMI and WC were significantly inversely associated with the presence of CAD in males, non diabetics, patients >60 years old and patients with Framingham risk score (FRS) >20% (P < 0.01 for all). The addition of BMI or WC in FRS-based regression models improved prediction of CAD (P = 0.03 and P < 0.001 for BMI and WC respectively) without a significant difference between the two models (P = 0.08). CONCLUSIONS: Central and overall obesity were independently associated with a reduced prevalence of angiographic CAD, lending further credence to the existence of the 'obesity paradox'. Obesity measures may further improve risk discrimination for the presence of CAD when added in an established risk score such as FRS.
No takes yet. Share an insight, caveat, or question.
Bechlioulis et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: